MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, CB2 0QQ, UK.
King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Int J Obes (Lond). 2024 Nov;48(11):1650-1655. doi: 10.1038/s41366-024-01605-4. Epub 2024 Aug 22.
Circulating insulin and insulin-like growth factor-1 (IGF-1) concentrations are positively correlated with adiposity. However, the causal effects of insulin and IGF-1 on adiposity are unclear.
We performed two-sample Mendelian randomization analyses to estimate the likely causal effects of fasting insulin and IGF-1 on relative childhood adiposity and adult body mass index (BMI). To improve accuracy and biological interpretation, we applied Steiger filtering (to avoid reverse causality) and 'biological effect' filtering of fasting insulin and IGF-1 associated variants.
Fasting insulin-increasing alleles (35 variants also associated with higher fasting glucose, indicative of insulin resistance) were associated with lower relative childhood adiposity (P = 3.8 × 10) and lower adult BMI (P = 1.4 × 10). IGF-1-increasing alleles also associated with taller childhood height (351 variants indicative of greater IGF-1 bioaction) showed no association with relative childhood adiposity (P = 0.077) or adult BMI (P = 0.562). Conversely, IGF-1-increasing alleles also associated with shorter childhood height (306 variants indicative of IGF-1 resistance) were associated with lower relative childhood adiposity (P = 6.7 × 10), but effects on adult BMI were inconclusive.
Genetic causal modelling indicates negative effects of insulin resistance on childhood and adult adiposity, and negative effects of IGF-1 resistance on childhood adiposity. Our findings demonstrate the need to distinguish between bioaction and resistance when modelling variants associated with biomarker concentrations.
循环胰岛素和胰岛素样生长因子-1(IGF-1)浓度与肥胖呈正相关。然而,胰岛素和 IGF-1 对肥胖的因果影响尚不清楚。
我们进行了两样本孟德尔随机化分析,以估计空腹胰岛素和 IGF-1 对儿童期相对肥胖和成人体重指数(BMI)的可能因果影响。为了提高准确性和生物学解释,我们对与空腹胰岛素和 IGF-1 相关的变异体应用了 Steiger 过滤(避免反向因果关系)和“生物学效应”过滤。
空腹胰岛素升高的等位基因(35 个变异体也与较高的空腹血糖相关,表明存在胰岛素抵抗)与较低的儿童期相对肥胖(P=3.8×10)和较低的成人 BMI(P=1.4×10)相关。IGF-1 升高的等位基因(351 个变异体表明 IGF-1 生物活性增强)与儿童期身高较高相关,与儿童期相对肥胖(P=0.077)或成人 BMI(P=0.562)无关。相反,IGF-1 升高的等位基因(306 个变异体表明 IGF-1 抵抗)与儿童期相对肥胖较低相关(P=6.7×10),但对成人 BMI 的影响尚无定论。
遗传因果模型表明,胰岛素抵抗对儿童和成人肥胖有负面影响,IGF-1 抵抗对儿童肥胖有负面影响。我们的研究结果表明,在对与生物标志物浓度相关的变异体进行建模时,需要区分生物活性和抵抗性。